Brief: Axichem Presents Promising Data From Clinical Study On Phenylcapsaicin

aXichem AB (publ)

18/08/2022 15:03

Aug 18 (Reuters) - aXichem AB (publ)  AXIC.ST :
    * AXICHEM PRESENTS PROMISING DATA FROM CLINICAL STUDY
REGARDING
PHENYLCAPSAICIN'S IMPACT ON SERUM ZONULIN LEVELS AND IMPROVED
BODY WEIGHT COMPOSITION IN HUMANS
    * RESULT INDICATES DAILY INTAKE OF PHENYLCAPSAICIN, AT LOW
DOSE,
IS LIKELY TO HAVE POSITIVE IMPACT ON HUMANS WITH LEAKY GUT
SYNDROME

Source text for Eikon:  ID:nWkr41qHGG 
Further company coverage:  AXIC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))